Related by context. All words. (Click for frequent words.) 86 Announce License Agreement 85 Announce Licensing Agreement 85 Announces Licensing Agreement 83 Sign Licensing Agreement 83 Signs License Agreement 83 Signs Licensing Agreement 83 Announces License Agreement 82 Begins Shipment 82 Announce Collaboration Agreement 81 Collaborates With 81 Announce Merger Agreement 81 Files Patent Application 81 Enters Into License Agreement 80 Announces FDA Clearance 80 Announce Collaboration 80 Announces Immediate Availability 80 Unveils Innovative 80 Completes Merger With 80 Introduces Revolutionary 80 Files IND 80 Develop Next Generation 80 Introduces Next Generation 80 Expands Portfolio 80 Introduces Breakthrough 79 Settle Patent Dispute 79 Unveils Latest 79 Finalizes Acquisition 79 Announce Availability 79 Settle Patent Litigation 79 Commercializes 79 Expand Collaboration 79 Achieves ISO #:# Certification [002] 79 Extend Collaboration 79 Settles Patent Litigation 78 Receives Patent 78 Awarded Patent 78 Settles Patent Dispute 78 Begins Shipping 78 Licenses Patents 78 Licenses Novel 78 Introduces Enhanced 78 Spins Off 78 Files Patent 78 Unveils Next Generation 78 Amends Agreement 78 Delivers Next Generation 78 Receives FDA Clearance 78 Submits Application 78 Completes Patient Enrollment 78 Inks Licensing Deal 78 Launches Next Generation 78 Initiates Enrollment 78 Gets FDA Clearance 77 Enters Into Licensing Agreement 77 Introduces Innovative 77 FDA Clears 77 Named Exclusive Distributor 77 Unveils Newest 77 Appoints Seasoned 77 Receives Favorable 77 Expand Relationship 77 Showcases Innovative 77 Q3 Loss Narrows 77 Acquire Assets 77 Inks Pact 77 Enters Into Exclusive 77 Unveils Revolutionary 77 Receives Approvable Letter 77 Introduces Powerful 77 Receives Orphan Drug Designation 77 Forges Partnership 76 Strengthens Its 76 Q1 Loss Narrows 76 Extend Partnership 76 Settles Litigation 76 Successfully Completes Acquisition 76 Successfully Completes Tender Offer 76 Completes Merger 76 Releases Next Generation 76 Shareholders Approve Acquisition 76 Extends Collaboration 76 Streamlines Operations 76 Q3 Loss Widens 76 Q2 Loss Narrows 76 Receives Milestone Payment 76 Jointly Develop 76 Completes Enrollment 76 Announces Favorable 76 Develop Novel 76 Strengthens Position 76 Expands Capabilities 76 Initiates Clinical Trial 76 Introduces Unique 76 Acquires Controlling Interest 76 Awarded Patents 76 Obtains Exclusive License 76 Acquires Assets 76 Terminates Agreement 76 Launches Unique 76 Announce Exclusive 76 Jumps Higher 76 Achieves Milestone 76 Successfully Concludes 76 Announces Additions 75 Announce Agreement 75 Files Shelf Registration Statement 75 BioSante Pharmaceuticals Announces 75 Introduces Novel 75 Q2 Loss Widens 75 Discontinues 75 Restructures Operations 75 Receives Certification 75 Confirms Commitment 75 Sinks Lower 75 Announces Organizational Changes 75 Ink Deal 75 Unveils Groundbreaking 75 Taglich Brothers Initiates Coverage 75 Receives Clearance 75 Signs Reseller Agreement 75 Spins Out 75 Appoints Experienced 75 Initiates Dosing 75 Q4 Loss Narrows 75 Signs Merger Agreement 75 Enters Joint Venture 75 Presents Preclinical Data 75 Debuts Next Generation 75 Signs Agreements 75 Enrolls First 75 Subsidiary Enters 75 Develops Breakthrough 75 Q1 Loss Widens 75 Therapeutic Competitors Report 75 Announce Joint Venture 75 Buys Majority Stake 75 Inks Distribution 75 Announces Definitive Agreement 75 Wins Patent Infringement 75 Starts Shipping 75 Presents Positive 75 Finalize Agreement 75 Obtains Approval 75 Announces Publication 75 Announces Initiation 75 Provides Update Regarding 75 Aquires 75 Secures Financing 75 Obtains License 75 Showcases Latest 75 Enters Agreement 75 Settle Litigation 75 Announces Signing 74 Inks License 74 Demonstrates Next Generation 74 Enters Into Joint Venture 74 Completes Reverse Merger 74 Completes Purchase Of 74 Initiates Phase II 74 Enters Strategic 74 Complete Merger 74 Buy Privately Held 74 Signs Distribution 74 Further Strengthens 74 Launches Groundbreaking 74 Ships #th 74 Submits NDA 74 PRODUCT SOURCE 74 Secures Contract 74 Thewallstreetleader.com Profiles 74 Announces Tentative Approval 74 Stockholders Approve Merger 74 Develops Innovative 74 DayTradersDigest.com Profiles 74 Enters Into Strategic 74 Completes Tender Offer 74 Achieves Significant 74 Acquires Exclusive 74 Launches Redesigned Website 74 Therapeutic Competitors Companies 74 Broadens Its 74 AUDIO PROVIDED BY 74 Inks Deal With 74 Restructures Debt 74 Releases Enhanced 74 Patent Issued 74 Announces Divestiture 74 Submits IND 74 Terminates Contract 74 Files Patent Infringement 74 Demonstrates Latest 74 Jointly Announce 74 Introduces Affordable 74 Completes Expansion 74 Secures Funding 74 Announces Reseller Agreement 74 Expands Capacity 74 Initiates Clinical 74 Exploring Strategic Alternatives 74 FY# Loss Widens 74 Receives CE Marking 74 Announces Dismissal 74 Shareholders Approve Merger Agreement 74 Expands Deployment 74 Finalizes Purchase 74 Guides Inline 74 Motorola Invests 74 Expands Relationship With 74 Inks Deals 74 Receives NASDAQ 74 Platform Enables 74 Provides Preliminary 74 MARKETING AGREEMENTS PRODUCT SOURCE 74 Announces Termination 74 Q4 Loss Widens 74 Reports Receipt 74 Explore Strategic Alternatives 74 Completes Installation 74 Flagship Product 74 Achieves ISO # 74 Announces Successful Completion 74 Introduces Newest 74 Initiates Clinical Trials 74 Completes Integration 74 Earnings Postmortem 74 Net Loss Narrows 74 Extends Relationship 74 Receives Positive 74 Closes Acquisition Of 73 Distribution Pact 73 Announces Formation 73 Licensing Deal 73 Accelerate Commercialization 73 Successfully Completed 73 Unveils Breakthrough 73 Licensing Pact 73 Achieves Breakthrough 73 Reports Positive 73 Announces Sponsorship 73 Renews Agreement 73 License Pact 73 Completes Acquisitions 73 Receives Tentative Approval 73 AllPennyStocks.com Spotlights 73 Receives Favorable Ruling 73 Regains Compliance With 73 Awarded GSA Schedule 73 Welcomes Analyst Initiation 73 Enters Into Agreement 73 Reveals Positive 73 Releases Latest 73 Net Loss Widens 73 Introduces Expanded 73 Delivers Breakthrough 73 Announce Definitive Agreement 73 Doubles Capacity 73 Restructures 73 Successfully Launches 73 Announce Completion 73 Enter Into 73 Completes Successful 73 FY# Loss Narrows 73 Sign Definitive Agreement 73 Dramatically Expands 73 Changes Ticker Symbol 73 Announces Enhancements 73 Shareholders Approve Merger 73 Unveils Expanded 73 Signs Licensing 73 Announce Expanded 73 Strengthens Leadership 73 Regains Compliance 73 Boosts Productivity 73 Acquirer Company 73 Announces Stockholder Approval 73 Sharpens Focus 73 Submits Biologics License Application 73 Expands Internationally 73 CybeRelease Decliners 73 Announce Launch 73 Provides Shareholder 73 Launches Innovative 73 Completes Divestiture 73 Significantly Increases 73 Develop Innovative 73 Announces Discontinuation 73 Demonstrates Significant 73 Announces Early Termination 73 Receives SFDA Approval 73 Launches Enhanced 73 Extends Reach 73 Terminate Merger Agreement 73 Achieves Certification 73 TRADESHOW SOURCE 73 Posts Wider Loss 73 Board Authorizes 73 Secures Additional 73 Q2 Adj 73 AGREEMENTS SOURCE 73 Retains CCG Investor Relations 73 Completes Reorganization 73 Q1 Adj 73 Signs MOU 73 Updates Outlooks 73 Amend Merger Agreement 73 Settles Patent Suit 73 Present Preclinical Data 72 Anounces 72 Deliver Presentation 72 Expands Availability 72 Posts Narrower Loss 72 Enable Next Generation 72 Posts Strong 72 Finalizes Agreement 72 Settles Dispute 72 Sign Reseller Agreement 72 Extend Relationship 72 Demonstrate Innovative 72 Announces Expanded 72 Receives Confirmation 72 Demonstrate Next Generation 72 Bearish MACD 72 Launches Expanded 72 Officially Launches 72 NewsBite Downgrade Puts Pressure 72 Inks Agreement 72 Ramps Up Production 72 Inks Deal 72 Announces Revised 72 Autodesk Completes Acquisition 72 Terminates Merger Agreement 72 Completes Acquisition 72 Acquire Controlling Interest 72 Signs Pact 72 Other OTC MNDP 72 Provides Comprehensive 72 Strengthens Balance Sheet 72 Enters Oversold Territory 72 MARKETING AGREEMENTS SOURCE 72 Lowers Guidance 72 Revitalizes 72 Annouces 72 CONFERENCE CALLS EARNINGS SOURCE 72 Exercises Option 72 CONFERENCE CALLS SOURCE 72 Manufacturer Selects 72 Mutually Agree 72 COMUNICADO DE 72 Drug Candidate 72 COMPLETES ACQUISITION OF 72 Restate Financials 72 Secures Patent 72 Extends Commitment 72 Successfully Integrates 72 Issued Patent 72 Establish Joint Venture 72 Completes Recapitalization 72 Deliver Powerful 72 Announce Settlement 72 Significantly Reduces 72 Expands Relationship 72 Adopts Cadence 72 Announce Strategic 72 Q1 Profit Surges 72 Acquire Privately Held 72 Jointly Launch 72 Revolutionizes 72 Signs Exclusive 72 Joins Hands 72 Develops Next Generation 72 Begins Dosing 72 PROFILE CO 72 Ink Pact 72 Announces Departure 72 Stockholders Approve Acquisition 72 Receives Funding 72 Unveils Powerful 72 Achieves Positive 72 Completes Transition 72 Successfully Deploys 72 Announces Effective Date 72 Canaccord Genuity Maintains Hold 72 Receives Notification 72 Amplifies 72 Announce Partnership 72 Announces Intent 72 Expands Scope 72 Strengthens Commitment 72 Closes Acquisition 72 Unsolicited Proposal From 72 Enhances User Experience 72 Reduces Debt 72 Signs Purchase Agreement 71 Seeks Approval 71 Rebrands 71 Formalizes 71 Winning Streak Continues 71 Completes Restructuring 71 Expands Distribution 71 Announces Addition 71 Confirms Receipt 71 Completes Asset 71 Announces Expansion 71 Expands Offerings 71 Calls Purchased 71 Receives Approval From 71 Successfully Tested 71 Q3 Adj 71 Fortifies 71 Subsidiary Acquires 71 Enters Into Definitive Agreement 71 Extends Relationship With 71 Regains Nasdaq 71 Establishes Joint Venture 71 Announce Breakthrough 71 Deliver Innovative 71 Withdraws Application 71 Finalizes Sale 71 Demonstrates Innovative 71 Achieves Record 71 Unveils Upgraded 71 Releases Latest Version 71 Could Revolutionize 71 Reports Significantly Improved 71 Introduce Next Generation 71 Updates Guidance 71 Attracting Bullish Investors 71 Presents Positive Preclinical 71 Attains 71 Inks MOU 71 Announce Early Termination 71 Wins Approval 71 Board Unanimously Rejects 71 Receives Unsolicited 71 Latest Addition 71 Achieves Record Sales 71 Settle Patent 71 Demonstrate Latest 71 Announce Expiration 71 Acquires Majority Stake 71 Provides Updates 71 Inc. OTCBB MNDP 71 Ventures Invests 71 Provide Comprehensive 71 Announce Licensing 71 Awarded GSA 71 Receives Notice From 71 Unveils Enhanced 71 Updates Status 71 Awarded Multi 71 Announce Interoperability 71 Commenced Against 71 Showcases Next Generation 71 Receives Commitment 71 Announces Rebranding 71 Announce Commencement 71 Changes Name 71 Demonstrates Potential 71 Shows Promise 71 Obtains Exclusive Rights 71 Flamel Technologies Announces 71 Bearish Speculation 71 Sets Second Quarter 71 Delivers Enhanced 71 Acquires Majority 71 Q2 Profit Soars 71 Reach Settlement Agreement 71 Sees Significant 71 Commences Phase 71 SWOT Analysis Aarkstore Enterprise 71 Successfully Delivers 71 Wins Summary Judgment 71 Q4 Profit Surges 71 VP Exercises Options 71 Unveil Next Generation 71 Closes Merger 71 Novartis Novo Nordisk 71 Announces Presentation 71 Successfully Passes 71 Broadens Scope 71 Acquires Remaining Interest 71 Inks Licensing Agreement 71 Deliver Next Generation 71 MANAGEMENT CHANGES SOURCE 71 Expands Functionality 71 Celebrates Successful 71 Outlines Strategy 71 Completes Buyout 71 Provides Guidance 71 COO Exercises Options 71 Announces Shareholder Approval 71 Successfully Demonstrates 71 PAUL Minn.MN 71 Shareholders Approve Sale 71 Significantly Enhances 71 Finalizes Purchase Of 71 Q4 Profit Climbs 71 Completes Financing 71 Completes Purchase 71 Updates Fourth Quarter 71 Subsidiary Receives 71 Reports Profitable 71 Attains Gold Certified Partner 71 Introduces Groundbreaking 71 Subsidiary Signs 71 Executes Agreement 71 Improves Efficiency 71 MONSTERSTOX.COM Monsterstox.com 71 Revises Fourth Quarter 71 Files Patents 71 Provides Updated 71 Forges Strategic 71 Daytradersdigest.com Profiles 71 Rated Speculative Buy 71 Movers Roundup 71 Inc. LATEST NEWS 71 Announce Initiation 71 Bullish Speculation 71 Regains Full 71 Awarded Contract Extension 71 Concludes Successful 71 Announce Formation 71 Gets Approval 71 Increases Ownership 71 Retains Investor Relations 71 Announces Availability 71 CRWEWallstreet.com Stock Report 71 Takes Majority Stake 71 Receives Recognition 71 Plans Job Cuts 71 Announces Job Cuts 71 Underscores Commitment 71 Wins Coveted 71 Commences Operations 71 News Unternehmensnachrichten 71 TheWallStreetLeader.com Profiles 71 Delivers Innovative 71 Q2 Profit Surges 71 Realigns 71 Moving Average Crossover Alert 71 Obtains Patent 71 Updates Shareholders 70 Announces Acquisition 70 Signs Agreement 70 Reacquires 70 INTRODUCES NEW 70 Significantly Improves 70 Becomes Authorized 70 Stock Downgraded 70 Formally Launches 70 Delivers Comprehensive 70 Enters Exclusive 70 Director Exercises Options 70 TSX Delisting Review 70 FDA Okays 70 Announce Reseller Agreement 70 Revises Guidance 70 Announces Postponement 70 Announces Commencement 70 Announces Upcoming 70 Strengthens Relationship 70 Guides Below 70 Patent Lawsuit 70 Furthers 70 Retains Leading 70 3Q Loss Widens 70 Secures Long Term 70 Releases Upgraded 70 3M Completes Acquisition 70 Joins OTCQX 70 Initiates Phase III 70 Completes Initial 70 Posts Quarterly 70 Posts Wider 70 Lowers Price 70 Engages CHF Investor Relations 70 Guides FY# Quick Facts 70 CFO Exercises Options 70 Trims Loss 70 Unveil Latest 70 Narrows Loss 70 Deliver Integrated 70 Announce Merger 70 Q3 Profit Surges 70 Puts Purchased 70 Successfully Tests 70 Post Earnings Checkup 70 Withdraws Proposal 70 #.#.# Meldung [001] 70 Expands Presence 70 Closes Previously Announced 70 Unwraps 70 Consummates 70 Successfully Completes Phase 70 Remains Neutral 70 Reaffirms Commitment 70 Doubles Size 70 Announces Positive 70 Voluntarily Withdraw 70 CFO Resigns 70 CEO Exercises Options 70 Extends Tender Offer 70 Markettelegraph.com 70 Successfully Complete 70 Receives Conditional 70 Reconfirms 70 Collaborators Publish 70 Completes Sale 70 Extends Capabilities 70 Inks Multi 70 Q3 Profit Soars 70 Adopts Shareholder Rights 70 Enlarges 70 Hold Fourth Quarter 70 Signs Definitive Agreement 70 Completes Previously Announced 70 Announces Recapitalization 70 Regains NASDAQ 70 Demonstrates Commitment 70 SVP Exercises Options 70 Engages Investor Relations 70 Broadens Product 70 Dramatically Increases 70 WeissComm Partners +#-#-#-# 70 Jointly Offer 70 Completes Refinancing 70 PerkinElmer Acquires 70 Demonstrates Interoperability 70 Bullish Average Crossover 70 Repositions 70 Increases Stake 70 Teledyne Acquires 70 Successfully Closes 70 Nasdaq XTLB 70 Trend Continues Down 70 Boosts Guidance 70 Receives Notice 70 Declares Dividend Quick Facts 70 Granted Orphan Drug 70 Receives Prestigious Award 70 Expands Scientific Advisory 70 Finalizes Merger 70 &Amp; 70 Achieves ISO 70 Relaunches 70 Deliver Comprehensive 70 Inc. Nasdaq OXGN 70 Announces Preliminary 70 Shares Slump 70 Delivers Strong 70 Files Definitive Proxy 70 Selects Camstar 70 Narrows Guidance 70 Provide Enhanced 70 Receives Notice Regarding 70 Earns Certification 70 Deliver Enhanced 70 Announces Issuance 70 Previews Earnings 70 Continues Aggressive 70 Gets Favorable 70 Endures Analyst Downgrade 70 Q4 Profit Plunges 70 Achieves Milestones 70 Closes Sale 70 Identifies Key 70 Wins Prestigious Award 70 Magazine Recognizes 70 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 70 Win Prestigious 70 Shares Soar 70 Develops Novel 70 Canaccord Genuity Reiterates Buy 70 Guides FY# Update 70 Patent Infringement Lawsuit Against 70 Q1 Profit Decreases 70 Takes Stake 70 Earns Milestone Payment 70 Cuts Costs 70 FDA Accepts 70 Commences Cash 70 Announce Receipt 70 Receives ISO #:# [001] 70 Delivers Powerful 70 Losses Narrow 70 Announces Stock Repurchase 70 * vwd BUSINESS WIRE 70 Announces Cancellation 70 Scoops Up 70 Options Activity 70 INDICATED LOWER 70 Announces Proposed 70 Website Launched 70 Files Patent Infringement Lawsuit 70 Resolves Dispute 70 -Pahuta 70 Posts 4Q 70 Ups Guidance 69 Awarded Prestigious 69 Announces Filing 69 Introduces Rugged 69 Awarded Qualifying Therapeutic 69 Expand Into 69 Forms Joint Venture 69 Announces Poster Presentations 69 Shares Climb 69 Receives Subpoena 69 Delivers Improved 69 ADVISORY CONFERENCE CALLS SOURCE 69 Shares Plummet 69 Files Annual Report 69 Files Registration Statement 69 Exec Joins 69 Makes Bearish 69 FDA Approves 69 Acquire Majority Stake 69 Provides Clarification 69 Accepted Into 69 Patent Lawsuit Against 69 Revolutionises 69 Submits Response 69 CONTINUES UP 69 Submits Bid 69 Meets Primary Endpoint 69 Named Fastest Growing 69 Announces Adjournment 69 Purchases Moore Microprocessor 69 Patent Dispute 69 Settles Patent Lawsuit 69 Becomes Exclusive 69 Procures 69 Forges Ahead 69 Therapeutic Competitors companiesandmarkets.com adEgemonye 69 Software Simplifies 69 Announces Proposed Acquisition 69 Toshiba Develops 69 Bullish Engulfing Pattern 69 Commences Production 69 Announces Launch 69 Signs Definitive 69 Trims Outlook 69 THE TREND CONTINUES DOWN 69 Receives Orphan Drug 69 overname 69 Q4 Profit Soars 69 Brings Unprecedented 69 Enables Rapid 69 Patent Infringement Suit Against 69 Receives Authorization 69 Renews Partnership 69 ANADIGICS Announces 69 Delays Filing 69 Enters Into Partnership 69 Receives Approval 69 Daytradersdigest.com 69 Patent Infringement Litigation 69 Announces Successful 69 Concludes Acquisition 69 Becomes Newest 69 Signs Joint Venture 69 Expands Commitment 69 Commercialize 69 Successfully Completes 69 Reaches Settlement Agreement 69 Completes Sale Of 69 Shows Promising 69 Adopts Stockholder Rights 69 Signs Long Term 69 Abandons Plans 69 Host Teleconference 69 Solution Enables 69 Stock Upgraded 69 Gets Clearance 69 Reports Preclinical Data 69 Continues Commitment 69 Adopts Synopsys 69 Patent Infringement Lawsuit 69 Launches Breakthrough 69 OTCStockExchange.com Stock Alert 69 Merger Creates 69 Registration Statement Declared Effective 69 Evaluate Strategic Alternatives 69 * vwd PRN 69 Uses SolidWorks 69 Enters Into Long Term 69 Refocuses 69 Receives ISO #:# [002] 69 Reduces Cost 69 Maintains Hold Rating 69 MERGERS ACQ SOURCE 69 Revises Third Quarter 69 Technicals Showing Bullish 69 Jointly Promote 69 Cites Positive 69 Guides Above 69 Buy Majority Stake 69 PARTNERS WITH 69 Files Shelf Registration 69 Inc Therapeutic Competitors 69 Reduces Size 69 Accelerates Expansion 69 Delivers Unparalleled 69 Q1 Profit Plunges 69 Acacia Subsidiary Enters 69 Subsidiary Completes 69 Announces Affiliation 69 Snaps Up 69 http:/www.Send2Press.com SOURCE 69 Penetrates 69 Complies With 69 Extends Expiration Date 69 Receives Stockholder Approval 69 Acquire Stake 69 Shares Surge 69 Has Spiked 69 Expands Globally 69 Mass.MA 69 Equipment Deals 69 Conference Call TRANSCRIPT 69 Options Trader Alert 69 Offers Affordable 69 Jointly Developed 69 Forms Strategic 69 Receives Delisting Notice 69 Put Volume Surges 69 otcstockexchange.com 69 Acacia Subsidiary 69 Bullish Technical Alert 69 Host Fourth Quarter 69 Approve Merger 69 Relaunches Website 69 Posts 2Q 69 Offers Unprecedented 69 IIROC Halt 69 Withdraws Offer 69 Completes Transaction 69 IIROC Resume 69 Slashes Price 69 Reduces Workforce 69 Initiates Voluntary Recall 69 Significantly Expands 69 Signs Definitive Agreements 69 Files Voluntary 69 Provides Unprecedented 69 Lowers Q4 69 Affirms Commitment 69 Summarizes 69 Stock Plunges 69 Announces Stock Buyback 69 Gobbles Up 69 Settle Dispute 69 Explores Strategic Alternatives 69 :/ finance.yahoo.com q 69 Signs LOI 69 OTC BB NECO 69 Kevin Matras Highlights 69 Trend Continues Lower 69 Media NewsEdge STOCK MARKETING 69 Named CES Innovations 69 Stays Neutral 69 Lauches 69 Increases Productivity 69 Achieves ISO #:# Certification [001] 69 CEO Discusses F#Q# [001] 69 Increases Commitment 69 Presents Preclinical 69 Continues Momentum 69 Technol 69 Obtains FDA 69 Obtains Exclusive 69 Announces Ticker Symbol 69 Collaborates 69 Expand Presence 69 Expert Joins 69 Files Countersuit Against 69 Corp. OTC SOPK 69 Reorganizes 69 TSMC Collaborate 68 Kyocera Lenovo palmOne 68 Posts Solid 68 widens Quick Facts 68 Signs Option Agreement 68 Receives Prestigious 68 High Growth Forecasted 68 Commercialize Novel 68 Stockholders Approve Merger Agreement 68 Present Keynote Address 68 Inc.today announced 68 Initiates Phase 2b 68 Initiates Phase 68 ADDING MULTIMEDIA 68 Subsidiary Enters Into 68 researches develops licenses 68 Finalizes Joint Venture 68 Extends Leadership 68 Reaffirms FY# Outlook 68 Wins Prestigious 68 Extends Contract 68 Q2 Profit Rises 68 Finalises 68 Renegotiates 68 SIGNS AGREEMENT WITH 68 Enters Into Collaboration 68 Celebrates Tenth Anniversary 68 Supercharges 68 BIOTECHNOLOGY SOURCE 68 Offers Unique 68 Downtrend Spotted 68 Earnings Scorecard 68 INTRODUCES 68 Signs Definitive Merger Agreement 68 DIEGOCA 68 Q2 Profit Declines 68 Novartis Organon 68 Q1 Profit Declines 68 Successfully Installs 68 Momentum Continues 68 Taro Receives 68 Achieves Prestigious 68 Announces Receipt 68 Expands Lineup 68 Customizes 68 Announce Successful Completion 68 BayStreet.ca Research Alert 68 Joins Forces 68 Reschedules Fourth Quarter 68 Posts Wider 4Q Loss 68 Establishes Strategic 68 Ups Bid 68 JAK2 Inhibitor 68 Renews Relationship 68 Tessera Licenses 68 Sanofi Aventis Schering Plough 68 Q1 Profit Soars 68 Canaccord Genuity Maintains Buy 68 EDN #/#/# [001] 68 Reminds Shareholders 68 Sells Shares 68 Recertified 68 THE TREND CONTINUES LOWER 68 Inc. Rated Speculative 68 & Sullivan Lauds 68 Q2 Profit Plunges 68 WEBBOLT Petrochemicals 68 Maintains Buy Rating 68 Ups Stake 68 Q3 Profit Rises 68 Review Strategic Alternatives 68 Reaffirms Outlook 68 Finalizes 68 Celebrates Decade 68 Receives Accolades 68 Q2 Profit Slips 68 Schedules Fourth Quarter 68 Q4 Profit Rises 68 & Sullivan Recognizes 68 Bulks Up 68 Strikes Deal 68 Completes Private Placement 68 Delivers Solid 68 Losses Widen 68 Puts Sold 68 Shareholders Approve 68 Inks Contract 68 Achieves SAS 68 Delivers Unprecedented 68 Slashes Guidance 68 IG HCR ;) CO 68 Leaps Ahead 68 Diversifies 68 Aligns 68 Subsidiary Wins 68 Shares Plunged What 68 Acquires 68 Settles Patent 68 Wins Contract 68 Achieves Highest 68 Begins Rollout 68 Confirms Significant 68 Boosts Buyback 68 Gets Favorable Ruling 68 AND ANNOUNCE 68 Celebrates Opening 68 Helps Reduce 68 Improves Customer Experience 68 Strengthens Presence 68 Files Investigational 68 Inks Exclusive 68 Issues Statement Regarding 68 Q3 Profit Decreases 68 Finalize Joint Venture 68 Pharmaceuticals Initiates 68 FDA Approvals 68 PRN FDA Approves 68 Q1 Profit Rises 68 Enters Negotiations 68 Expands Into 68 Unveils Enhancements 68 Reduces Risk